ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.23
      0.77%
      US Tech 100
      19,409.60
      1.26%
      Dow Jones
      38,778.10
      0.49%
      Brent Oil
      83.62
      -0.33%
      Bitcoin
      65,526.86
      -1.45%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Senti Biosciences Inc (SNTI)

      7. Senti Biosciences Inc (SNTI) News

      SNTI

      Senti Biosciences (SNTI)

      Senti Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SNTI
      DateTimeSourceHeadlineSymbolCompany
      05/29/20244:14PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SNTISenti Biosciences Inc
      05/29/20244:09PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SNTISenti Biosciences Inc
      05/29/20244:07PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNTISenti Biosciences Inc
      05/17/20245:19PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNTISenti Biosciences Inc
      05/17/20245:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNTISenti Biosciences Inc
      05/13/20248:15AMGlobeNewswire Inc.Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
      05/09/20244:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNTISenti Biosciences Inc
      05/09/20244:05PMGlobeNewswire Inc.Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate HighlightsNASDAQ:SNTISenti Biosciences Inc
      04/30/20248:05AMGlobeNewswire Inc.Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)NASDAQ:SNTISenti Biosciences Inc
      03/21/20244:05PMGlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
      01/05/20244:05PMGlobeNewswire Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical ProgramNASDAQ:SNTISenti Biosciences Inc
      12/22/20236:30AMGlobeNewswire Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid LeukemiaNASDAQ:SNTISenti Biosciences Inc
      11/13/20234:15PMGlobeNewswire Inc.Senti Bio Announces Third Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
      11/06/20234:05PMGlobeNewswire Inc.Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in ChinaNASDAQ:SNTISenti Biosciences Inc
      10/31/20239:06AMGlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual MeetingNASDAQ:SNTISenti Biosciences Inc
      09/27/20239:05AMGlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 MeetingNASDAQ:SNTISenti Biosciences Inc
      09/26/20234:05PMGlobeNewswire Inc.Senti Bio to Participate in Upcoming ConferencesNASDAQ:SNTISenti Biosciences Inc
      09/05/20238:30AMGlobeNewswire Inc.Senti Bio to Participate in Upcoming Investor ConferencesNASDAQ:SNTISenti Biosciences Inc
      08/11/20238:35AMGlobeNewswire Inc.Senti Bio Announces Second Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
      08/10/20238:35AMGlobeNewswire Inc.Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon PartnersNASDAQ:SNTISenti Biosciences Inc
      05/20/20238:05AMGlobeNewswire Inc.Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingNASDAQ:SNTISenti Biosciences Inc
      05/09/20234:05PMGlobeNewswire Inc.Senti Bio Announces First Quarter 2023 Results and Pipeline UpdatesNASDAQ:SNTISenti Biosciences Inc
      05/02/20234:45PMGlobeNewswire Inc.Senti Bio Announces Multiple Data Presentations at the American Society of Gene and Cell Therapy 2023 Annual MeetingNASDAQ:SNTISenti Biosciences Inc
      04/17/20238:45AMGlobeNewswire Inc.Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
      04/14/20239:00AMGlobeNewswire Inc.Senti Bio to Participate in Upcoming Investor ConferencesNASDAQ:SNTISenti Biosciences Inc
      03/22/20235:09PMGlobeNewswire Inc.Senti Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Reviews Recent HighlightsNASDAQ:SNTISenti Biosciences Inc
      03/14/20234:35PMGlobeNewswire Inc.Senti Bio Announces Three Preclinical Data Presentations from Gene Circuit-Enhanced CAR-NK Cell Oncology Pipeline at Annual AACR MeetingNASDAQ:SNTISenti Biosciences Inc
      02/03/20234:05PMGlobeNewswire Inc.Senti Biosciences Announces New Employment Inducement GrantsNASDAQ:SNTISenti Biosciences Inc
      02/01/20234:05PMGlobeNewswire Inc.Senti Bio to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:SNTISenti Biosciences Inc
      01/27/20238:00AMGlobeNewswire Inc.Senti Bio Announces Pipeline Prioritization to Focus on Logic Gated Cell Therapies; Updates Cash Runway GuidanceNASDAQ:SNTISenti Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:SNTI